Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
Authors
Keywords
-
Journal
ONCOGENE
Volume 32, Issue 46, Pages 5359-5368
Publisher
Springer Nature
Online
2013-03-11
DOI
10.1038/onc.2013.40
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prolonged Exposure to a Mer Ligand in Leukemia: Gas6 Favors Expression of a Partial Mer Glycoform and Reveals a Novel Role for Mer in the Nucleus
- (2012) Justine Migdall-Wilson et al. PLoS One
- Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia
- (2012) Jing Liu et al. ACS Medicinal Chemistry Letters
- Galectin-3 is a new MerTK-specific eat-me signal
- (2011) Nora B. Caberoy et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
- (2011) Ching-Hon Pui et al. JOURNAL OF CLINICAL ONCOLOGY
- Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial
- (2011) Markus Pfirrmann et al. LANCET ONCOLOGY
- Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia
- (2011) Steven M. Trifilio et al. LEUKEMIA RESEARCH
- A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells
- (2011) Kim J. Png et al. NATURE
- Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology
- (2011) A E J Rogers et al. ONCOGENE
- Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia
- (2010) C. Muller-Tidow et al. BLOOD
- Tubby and tubby-like protein 1 are new MerTK ligands for phagocytosis
- (2010) Nora B Caberoy et al. EMBO JOURNAL
- Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials
- (2010) A Sander et al. LEUKEMIA
- MSK1 activation in acute myeloid leukemia cells with FLT3 mutations
- (2010) T Odgerel et al. LEUKEMIA
- A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemia
- (2010) Anjali S. Advani et al. LEUKEMIA RESEARCH
- Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity
- (2010) A. K. Keating et al. MOLECULAR CANCER THERAPEUTICS
- Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006–2010
- (2009) D. Pulte et al. ANNALS OF ONCOLOGY
- Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia
- (2008) Chih-Chen Hong et al. CANCER LETTERS
- Increased C-kit intensity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AML
- (2007) Anjali S. Advani et al. LEUKEMIA RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started